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ABSTRACT
Messenger RNA (mRNA) 30 end formation is a
nuclear process through which all eukaryotic
primary transcripts are endonucleolytically cleaved
and most of them acquire a poly(A) tail. This
process, which consists in the recognition of
defined poly(A) signals of the pre-mRNAs by a
large cleavage/polyadenylation machinery, plays a
critical role in gene expression. Indeed, the poly(A)
tail of a mature mRNA is essential for its functions,
including stability, translocation to the cytoplasm
and translation. In addition, this process serves
as a bridge in the network connecting the differ-
ent transcription, capping, splicing and export
machineries. It also participates in the quantitative
and qualitative regulation of gene expression in a
variety of biological processes through the selection
of single or alternative poly(A) signals in transcrip-
tion units. A large number of protein factors associ-
ates with this machinery to regulate the efficiency
and specificity of this process and to mediate its
interaction with other nuclear events. Here, we
review the eukaryotic 30 end processing machineries
as well as the comprehensive set of regulatory
factors and discuss the different molecular mecha-
nisms of 30 end processing regulation by proposing
several overlapping models of regulation.
INTRODUCTION
In eukaryotes, 30 end cleavage of transcripts generated
by RNA polymerase II (pol II) is a universal step of
gene expression that proceeds through the recognition of
cis-acting elements of the pre-messenger RNA (mRNA)
[deﬁned as the poly(A) signal] by a complex machinery.
After cleavage, most pre-mRNAs, with the exception
of histone replication-dependent transcripts, acquire
a polyadenylated tail. 30 end processing is a nuclear
co-transcriptional process that promotes transport of
mRNAs from the nucleus to the cytoplasm and aﬀects
the stability and the translation of mRNAs.
Although cleavage and polyadenylation can be studied
as isolated processes in vitro, mRNA 30 end formation
in vivo is an integral component of the coupled network
in which the diﬀerent machines carrying out separate steps
of the gene expression pathway are tethered to each other
to form a gene expression factory. In this network, 30
end processing cross-talks with the transcription and
splicing steps to optimize the eﬃciency and speciﬁcity of
each enzymatic reaction (Figure 1) (1). The physical
interconnections between the splicing/transcription and
30 end processing machineries create a strong functional
interdependence. Indeed, 30 end polyadenylation factors
(or pA factors, including factors involved in both
cleavage and polyadenylation) and sequence elements
of the poly(A) signal modulate transcription termination
(2–5) and, in turn, transcription factors/activators aﬀect
processing at the poly(A) signal (6–9). The phosphory-
lated carboxyl-terminal domain (CTD) of pol II also
plays a major role in this coupling network by serving as
a gathering/delivering platform of pA factors and is
an integral component of the 30 end processing complex
(10,11). The functional interdependence between splicing
and 30 end processing is mediated by the molecular link
between splicing factors bound at the last intron 30 splice
site and pA factors associated to the poly(A) signal in the
terminal exon [(12–16) and references inside] and contrib-
utes to deﬁne the last exon of a pre-mRNA (17).
In addition to playing an essential role in the exten-
sive network that coordinates the activities of the dif-
ferent gene expression machineries, 30 end processing
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aspects of gene expression. In transcripts carrying a single
poly(A) signal, the function of the regulatory factors is to
deﬁne whether to process the transcript. The regulation of
the eﬃciency of poly(A) signal recognition will determine
the level of protein expression. Indeed, transcripts that are
not processed at the 30 end will be degraded or not trans-
ported eﬃciently to the cytoplasm. In transcripts contain-
ing more than one poly(A) signal, that is the majority of
the transcription units (18–20), the role of the regulatory
factors is to deﬁne where to process the transcript.
Alternative 30 end processing proceeds through the
choice of alternative pA signals located in the same exon
or in diﬀerent exons (Figure 1). The consequence of this
regulation is either to change the coding sequences,
resulting in diﬀerent protein isoforms, or the sequences
included in the 30 untranslated region (UTR) region,
resulting in transcripts which may diﬀer in their stability,
localization, transport and translation properties (21–24).
Processing at a single or multiple poly(A) signals not
only can be inﬂuenced by physiological conditions
(including cell growth, cell cycle position, diﬀerentiation
and development) but also can be altered in pathological
situations (including cancer, immunity and inﬂammation
and viral infection). The crucial role of 30 end processing
in gene expression is highlighted by the increasing number
of diﬀerent disease entities caused by defects in the forma-
tion of proper mRNA ends (25). Indeed, disruption of this
process can profoundly perturb cell viability, growth and
development.
The purpose of this review is to summarize the current
knowledge on the molecular mechanisms of eukaryotic 30
end processing regulation with particular emphasis on the
diﬀerent models of regulation supported by a comprehen-
sive account of examples known at present. Indeed, a
growing number of proteins have been identiﬁed as
regulators of the 30 end processing reaction (Table 1).
These can be factors involved in other steps of gene
expression (capping, splicing, transcription, stability/
translation and export) or proteins of the basic cleavage/
polyadenylation machinery. Their function in 30 end pro-
cessing may depend on their ability to bind auxiliary/
essential poly(A) signal sequences or to redistribute pA
factors in alternative complexes or in diﬀerent cellular
compartments. Post-translational modiﬁcation plays also
a critical role in the regulation of the assembly of this
machinery. More extensive reviews concerning various
aspects of mRNA 30 end formation and its implication
for health and disease can be found elsewhere (23,25–29).
THE EUKARYOTIC PRE-MRNA 30 END
PROCESSING MACHINERIES
The 30 end processing reaction requires multiple protein
factors that are generally conserved in eukaryotes and
assemble onto deﬁned sequence elements within the 30
end region of the pre-mRNA. Although the cis-elements
diﬀer in sequence and location among mammalian, yeast
and plant pre-mRNAs, there appears to exist a common
tripartite arrangement in which the cleavage site is
associated with one A-rich element and one or more
U-rich regions (Figure 2).
Metazoan 30 end processing machinery
The machinery leading to the formation of metazoan
polyadenylated mRNAs contains several sub-complexes
[Figure 2A, for a recent review see ref. 26], including
cleavage and polyadenylation speciﬁcity factor (CPSF),
cleavage stimulation factor (CstF), cleavage factor I
(CFIm), cleavage factor II (CFIIm), poly(A) polymerase
(PAP), symplekin and the pol II. All these factors contrib-
ute to the cleavage reaction. The addition of the poly(A)
tail, when tested in in vitro reconstituted assays, only
requires CPSF, PAP and the poly(A) binding protein
(PABP). PABP stimulates PAP to catalyze the addition
of adenosine residues and controls poly(A) tail length by
regulating the interaction between CPSF and PAP (30).
The poly(A) signal is deﬁned by two primary sequence
elements: the AAUAAA hexamer (or the more frequent
variant AUUAAA) found 10–30nt upstream of the
cleavage site that binds CPSF and the U/GU-rich region
located 30nt downstream of the cleavage site (downstream
sequence element or DSE) that associates with CstF.
Recognition of the poly(A) signal in the absence of the
canonical A(A/U)UAAA element primarily depends on
the presence of an upstream UGUA sequence motif
which functions in association with CFIm (31,32). The
optimal cleavage site is generally a CA dinucleotide and
cleavage is catalyzed by the 73-kDa subunit of CPSF at
the 30 side of the adenosine residue (33). Recently, the
puriﬁcation and subsequent proteomic identiﬁcation and
structural characterization of the human 30 end processing
complex revealed a complex architecture containing
 85 proteins, including new essential factors and over
50 proteins that mediate the interplay with other pro-
cesses. Among these factors, two proteins, the CPSF-
associated factor, WDR33 (WD repeat domain 33),
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Figure 1. The 30 end processing at single or multiple pA signals and its
interconnections with the splicing/transcription machineries. Alternative
30 end processing occurs through the selection of pA signals in the same
exon or in diﬀerent alternative exons. The physical and functional inter-
dependence between 30 end processing and transcription/splicing is rep-
resented by red/green dotted lines.
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have been shown to be required for the 30 end processing
reactions (34).
The eﬃciency of the 30 end processing reaction is modu-
lated by additional sequence elements located upstream
(upstream sequence element or USE) or downstream (aux-
iliary downstream sequence element or AuxDSE) of the
cleavage site. USEs are generally U-rich and serve as an
additional anchor for the 30 end processing machinery by
recruiting auxiliary or essential 30 end processing factors
(25,35–44). AuxDSEs are generally G-rich and function
by binding regulatory factors resulting in enhanced
mRNA 30 end formation (45–51).
Unlike polyadenylated mRNAs, histone pre-mRNAs 30
end processing is governed by a set of rigid constraints
that allow a precise coordination between regulation
of their expression and DNA replication signals
(Figure 2A; for recent reviews see refs 28 and 52). The
replication-dependent histone processing signal lies
within 100nt downstream of the stop codon and is
composed of a conserved stem–loop sequence and a
more variable purine-rich element (histone downstream
element or HDE) that begins 15–20nt downstream of
the stem–loop. The SLBP protein bound to the stem–
loop structure acts to stabilize the binding of the U7
snRNA incorporated in the U7snRNP to the HDE. This
interaction is bridged by a 100-kDa zinc ﬁnger protein
(ZPF100) and involves Lsm11, a component of the
U7snRNP that together with Lsm10 and the propaptotic
protein FLASH, are required for histone 30 end processing
(53,54). The replication-dependent histone 30 end process-
ing complex and the machinery producing polyadenylated
mRNAs share a common cleavage site, the CA
dinucleotide, and a core cleavage factor containing
symplekin, CPSF100 and CPSF73 (55), with the
endonuclease CPSF73 being the factor that cleaves the
pre-mRNA (56). CPSF100 is also important for
the cleavage reaction but it lacks residues critical for catal-
ysis (57). Symplekin is the temperature-sensitive compo-
nent of the essential heat-labile factor which also includes
CPSF and CstF subunits (58). While using common
catalytic core machinery, the histone processing reaction
diverges from the process originating polyadenylated
mRNAs in that it is a one-step process strictly dependent
on speciﬁc signal elements and is incompatible with
splicing. Although the transcription complex does not
stimulate histone 30 end processing (59), recent ﬁndings
undercover a physical and functional link between tran-
scription and 30 end processing factors playing a role in the
choice of the correct cleavage site to achieve the stem–loop
pathway (60).
Yeast 30 end processing machinery
The factors comprised in the 30 end processing apparatus
in mammals and in yeast are generally conserved but the
poly(A) signals in the two organisms are rather diﬀerent in
consensus sequence and organization (Figure 2B; for a
recent review see ref. 26). The yeast machinery comprises
the cleavage and polyadenylation factor (CPF), the
cleavage factor IA (CFIA) and the cleavage factor IB
(CFIB). CPF contains subunits that are homologous to
those in mammalian CPSF but distributed in two diﬀerent
sub-complexes, CFII and PFI, and include many addi-
tional factors, some of which are required for the 30 end
processing functions (including Pfs2, Ssu72, Mpe1, Glc7
and Ref2). The yeast homolog of symplekin, Pta1, is
included in CFII and serves as a scaﬀold protein that is
required for both cleavage and polyadenylation (61).
CFIA contains subunits that are homologous to those in
mammalian CFIIm and CstF, except for the absence of
CstF50 in yeast. Hrp1 is the only member of CFIB and
does not have a homolog in mammals. In vitro cleavage
requires only CFIA, CFIB and CFII, while in vitro
polyadenylation requires CPF, CFIA, CFIB and Pap1.
The pol II CTD is not essential for 30 end formation at
yeast poly(A) signals but it does enhance the eﬃciencies of
both cleavage and polyadenylation (62).The yeast poly(A)
signal is composed of three sequence elements: the
AU-rich eﬃciency element (EE), the A-rich positioning
element (PE) and the U-rich elements located upstream
(UUE) or downstream (DUE) of the cleavage site. The
latter is deﬁned by a pyrimidine followed by multiple
adenosines Y(A)n. In spite of the sequence homology,
the RNA-binding speciﬁcity, the positioning and the
speciﬁc function of the yeast factors are rather diﬀerent
from the mammalian counterpart. Indeed, in contrast to
mammalian CPSF160, which interacts with the AAUAA
A element, the yeast homolog, Yhh1, does not binds to the
PE, the yeast counterpart of the hexamer, but near the
A-rich cleavage site (63). Similarly, unlike mammalian
CstF64 which associates with the U/GU rich element
downstream of the cleavage site, the yeast homolog
Rna15, with the help of Rna14, recognizes the A-rich
PE located in the upstream region (64). As an example
of diﬀerent function between the yeast and mammalian
homologs, mammalian CstF is involved only in the
cleavage reaction, while the yeast multi-protein complex
CFI is necessary for both steps. Conversely, factors
without a clear sequence homology can share overlapping
functions. Hrp1, which resembles the mammalian
splicing factor hnRNP A1 in structure, shares several
features of the mammalian CFIm, i.e. the function in
both cleavage and polyadenylation, the positioning of
the binding site upstream of the cleavage site, the
post-translational modiﬁcations (arginine methylation)
and the association with the transcription unit [(32) and
references inside].
Plant 30 end processing machinery
Most human/yeast genes have homologs in plant
Arabidopsis genome, except for the mammalian factor
CFI (absent also in yeast) and the yeast factor Hrp1
(Figure 2C; for a recent review see ref. 27). The plant
cleavage/polyadenylation machinery is still forthcoming
but a working model starts to emerge. Arabidopsis
CPSF complex (AtCPSF) includes AtCPSF30,
AtCPSF73-I, AtCPSF73-II, AtCPSF100, AtCPSF160,
AtFIPS5 and AtFY. AtCPSF100 serves as the core of
the AtCPSF complex while AtCPSF30 is physically
linked to AtCstF via its interaction with AtFip, and
Nucleic Acids Research,2010, Vol.38, No. 9 2759mediates the interaction between CPSF and other factors,
such as AtCLPS3, AtSYM5, and AtPCFS4 (65). The
assembly of AtCPSF in plants is dynamic (65,66) and
the interactions between AtCPSF30 and other CPSF
subunits are diﬀerent from those existing in other
eukaryotes (66). Among the plant 30 end processing
factors, CPSF73(II) and FY are plant-speciﬁc proteins
and are involved in speciﬁc processes, such as plant
female development and ﬂowering. Unlike human/yeast
30 end processing factors that are encoded by single
genes, some Arabidopsis factors are encoded by modest
gene families (e.g. ref. 67). Another important diﬀerence
is that instead of being essential, as in yeast and
human, some Arabidopsis pA factors aﬀect only speciﬁc
biological functions, as is the case of AtCPSF30 (68,69).
The plant poly(A) signal is composed of three poorly
conserved sequence elements: a far-upstream U-rich
element (FUE), a near-upstream A-rich element
(NUE) and a U-rich element (CE) encompassing a
pyrimidine-adenosine dinucleotide that functions as the
cleavage site.
MECHANISTIC MODELS OF PRE-MRNA 30 END
PROCESSING REGULATION
The large complexity of the 30 end processing complexes
and the ﬂexibility of the associated auxiliary/essential
signal elements reﬂects the ability of this process to be
subjected to extensive regulation. Based on a comprehen-
sive set of examples of 30 end processing regulation in
eukaryotic organisms, several overlapping mechanisms
of action can be proposed as described below (Figure 3
and Supplementary Table S1).
Competition with pA factors for binding to a poly(A)
signal
Since the assembly of the polyadenylation machinery pri-
marily depends on the cooperative binding of CPSF and
CstF to the core polyadenylation signal (70), an eﬃcient
way to regulate 30 end processing is to impede the forma-
tion of this heterotrimeric complex by competing with the
basal pA factors for recognition of the core elements. In
most cases, the regulatory factors block the association of
CstF64 to the U/GU-rich DSE and this occurs by their
direct binding to the DSE or by their association with
elements in the close proximity of the DSE (Figure 3A).
A regulator which plays a negative function by
competing directly for binding sites with CstF is the
polypyrimidine tract binding protein (PTB), a major
hnRNP protein that plays multiple roles in mRNA metab-
olism, including mRNA 30 end formation (71). The
outcome of the competition between the two factors for
binding to the DSE might be determined by the relative
strength of the DSE and by the physiological variation in
PTB levels (72). PTB has been shown to inhibit the a-,
b-globin and complement C2 poly(A) signals (71) but,
since the DSE is commonly present in metazoan poly(A)
signals, this factor is expected to lead to a general
downregulation in mRNA expression.
The second mechanism of action depends on the
presence of auxiliary regulatory elements ﬂanking or par-
tially overlapping the DSE and, in most cases, is used to
repress the choice of alternative poly(A) sites. The U1A
Table 1. Proteins involved in 30 end processing regulation of eukaryotic pre-mRNAs
Factor Role RNA Sequence element Reference
Metazoan
14-3-3e   Most cellular pre-mRNAs (tested on c-mos) (126)
9G8 + HIV-1 Upstream consensus
9G8 binding site
(108)
BARD1   Expected general function (tested on SV40 late and AdL3) (135–137)
Cdc73 + Speciﬁc subset of pre-mRNAs including Integrator complex
subunit 6 (INT6)
(138)
CDK9 + Replication-dependent histones (159)
CFIm25   Pre-mRNAs with tandem pA signals including
Metallopeptidase inhibitor 2 (TIMP-2), Syndecan 2 and
Excision repair (ERCC6), Dihydrofolate reductase
(DHFR)
(122)
CFIm68 –/+ CFIm68 3 UGUAA motifs (31)
CFIm68 + poly(A) polymerase a (PAPOLA)
poly(A) polymerase g (PAPOLG)
UGUAA motifs
ﬂanking and
overlapping
non-canonical
poly(A) signal
(32)
CFIm68 CFIm25 + Non-canonical pA signals in male germ cell transcripts
including CFIm68 and CFIm25
UGUAA motifs (121)
CSR1 + Expected general function (tested on b-actin and GAPDH) (129)
CstF64 + IgM DSE (116,117)
A speciﬁc subset of pre-mRNAs including Inhibitor of DNA
binding 2 (Id-2) and Matrix metallopeptidase 9 (Mmp-9)
DSE (118)
Testis brain RNA-binding protein (TB-RBP) DSE (120)
NF-Atc DSE (119)
eIF3f   HIV-1 (108)
ELL2 + Immunoglobulin heavy chain locus Promoter (124)
(continued)
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Factor Role RNA Sequence element Reference
hnRNP F   IgM DSE (48)
hnRNP H + Melanocortin receptor 1 (MC1-R) G-rich AuxDSE (49)
Expected to inﬂuence a speciﬁc subset of pre-mRNAs (tested
on SV40 late and others)
G-rich AuxDSE (45,46,104)
Expected to inﬂuence a speciﬁc subset of pre-mRNAs
including b-globin
G-rich AuxDSE (50)
Rous sarcoma virus (RSV) Upstream negative
regulator of
splicing (NRS)
element
(160)
hnRNP I (PTB) + Cyclooxygenase-2 (COX-2) U-rich USE (40)
Complement C2 (C2) U-rich USE (35)
Glial ﬁbrillary acidic protein (GFAP) (161)
a-Tropomyosin Upstream
pyrimidine-rich
element
(162,163)
Expected to inﬂuence a speciﬁc subset of pre-mRNAs
including b-globin
Upstream
pyrimidine-rich
element
(50)
CT/CGRP Downstream
enhancer (50,3 0
splice sites and a
pyrimidine-rich
element)
(115)
A subset of pre-mRNAs including Prothrombin F2 (F2) U-rich USE (103)
hnRNP I (PTB)   Expected to inﬂuence many pre-mRNAs including b-globin,
a-globin and Complement C2 (C2)
DSE (71)
hnRNP L + Herpes simplex virus thymidine kinase (HSV-TK) Upstream
pre-mRNA pro-
cessing enhancer
(PPE)
(164)
hnRNP L + Expected to inﬂuence a speciﬁc subset of pre-mRNAs
including N-acylsphingosine amidohydrolase (acid
ceramidase) 1 (ASAH1)
(165)
HSF1 + Expected to inﬂuence Heat shock protein (HSP) pre-mRNAs
including Hsp70
(128)
Hu   Expected to inﬂuence a speciﬁc subset of pre-mRNAs
including CT/CGRP
U-rich sequences
close to
AAUAAA
(75)
IRBIT   Expected to inﬂuence a speciﬁc subset of pre-mRNAs (tested
on SV40 late)
AAUAAA (130)
NELF + Replication-dependent histones 50 cap (60)
Nova +/– Mouse brain transcripts YCAY-rich motifs
in the 30-UTR
(166)
P54 + Cycloxygenase-2 (COX-2) U-rich USE (40)
P54 Expected general functional (tested on model substrate SV40
late)
(167)
PIPK2a + Detoxiﬁcation and/or oxidative stress response transcripts (141)
PSF + Cyclooxygenase-2 (COX-2) U-rich USE (40)
Expected general function (tested on Gal5HIV2dsx reporter) (7)
Tested on SV40 late (167)
Sam68 + HIV-1 (168,169)
Slm1, Slm2 + HIV-1 (169)
Smicl + Expected to inﬂuence a speciﬁc subset of pre-mRNAs
including Xiro1
(139)
SR proteins
(9G8, SRp40,
SC35, ASF/SF2,
Srp55)
+ Glial ﬁbrillary acidic protein (GFAP) (161)
SR proteins
(SRp20,
ASF, 9G8)
+ Rous sarcoma virus (RSV) Negative Regulator
of Splicing
element (NRS)
(170)
SRm160 + Expected general regulator (tested on b-globin) (97,98)
SRp20 + CT/CGRP Downstream
enhancer (50 and
30splice sites and
a pyrimidine-rich
element)
(113,114)
(continued)
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Factor Role RNA Sequence element Reference
SRp75   Expected to inﬂuence a speciﬁc subset of pre-mRNAs (tested
on AdL3)
Artiﬁcial binding
site
(86)
U1 snRNP + CT/CGRP Downstream
enhancer (5– and
3–splice sites and
a pyrimidine-rich
element)
(114)
Expected general role (tested on SV40 late) Upstream binding
site
(171)
U1 snRNP   HIV-1 Downstream 5–
splice site
(172,173)
U1 snRNP
(U170K)
  Bovine papillomavirus (BPV) Upstream 5– splice
site
(85,173)
U1A   IgM Between GU-rich
elements at DSE
(73)
Upstream AUGC
motifs
(84)
U1A Upstream stem–
loop structure
(12,82,83)
U1A snRNP + SV40 late USE (101)
Expected general role (tested on SV40 late) USE? (100)
Cycloxygenase-2 (COX-2) USE (40)
U2 snRNP + Expected general role (tested on SV40 late) Branchpoint at the
upstream 30splice
site
(16)
Replication-dependent histones Upstream C/
GAAGAAG
motif
(96)
U2AF35
U2AF65
+ A subset of pre-mRNAs including Prothrombin F2 (F2) U-rich USE (103)
U2AF65 + Expected general role (tested on model substrate b-globin
and AdL3)
Pyrimidine tract at
the upstream 30
splice site
(14,15)
U2AF65   Expected to inﬂuence a speciﬁc subset of pre-mRNAs (tested
on albumin)
Poly(A)-limiting
element (PLE)
(174)
Expected to inﬂuence a speciﬁc subset of pre-mRNAs (tested
on AdL3)
Artiﬁcial binding
site
(86)
tcstf64 Mouse testes transcripts (175)
Plant
CLPS3 + Speciﬁc subset of pre-mRNAs including FCA (176)
FCA + Speciﬁc subset of pre-mRNAs including FCA (102,177)
PCFS4 + Speciﬁc subset of pre-mRNAs including FCA (67)
Yeast
Cth2 + Adenosine/uridine-rich elements (ARE)-containing transcripts
including Membrane anchor subunit of succinate
dehydrogenase (SDH4)-
ARE (178)
Nab4/hrp1 + Speciﬁc subset of pre-mRNAs including Yeast homolog of
human TFIIB (SUA7), copper transporter 2 (CTR2) and
others
UA-rich element
upstream CS
(179)
Speciﬁc subset of pre-mRNAs including Iso-1-cytochrome c
(CYC1) and GAL7
(180)
Npl3   Npl3 (154)
Npl3 Expected general role (tested on GAL7) UA repeat and
A-rich, UG
motifs
(79)
Virus
ICP27 + Herpes Simplex Virus 1 (HSV-1) and other pA signals (133,181)
a-globin (182)
NS1   Most cellular transcripts (tested also on b-actin) (131,132)
SM + Epstein–Barr virus (EBV) DNA polymerase (183)
Fly
ELAV - Erect wing (Ewg) Downstream
tandem AU-rich
motifs
(95)
SXL - Enhancer of rudimentary (e(r)) GU-rich DSE (77)
HIV-1, human immunodeﬁciency virus type 1; SV40 late, simian virus 40 late; AdL3, adenovirus L3; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; IgM, immunoglobulin M heavy chain; CT/CGRP, calcitonin/calcitonin gene-related peptide; FCA, ﬂowering time control protein;
GAL7, galactose-1-phosphate uridyl transferase.
2762 Nucleic Acids Research, 2010,Vol.38, No. 9splicing factor binds in between two GU-rich regions
downstream of the secretory poly(A) site of the
immunoglobulin M (IgM) heavy chain pre-mRNA and
inhibits both the binding of CstF64 to the GU-rich
region and cleavage at this poly(A) site, resulting in
polyadenylation switching at the membrane poly(A) site
(73). The antagonistic binding of U1A and CstF64 can be
explained by the observation that the U1A binding site
extends to the adjacent distal GU-rich region, thus
blocking the access of CstF64 to this element (73). Using
a similar competition mechanism, the splicing factor
hnRNP F hinders the assembly of a stable polyadeny-
lation complex at the IgM secretory-speciﬁc poly(A) site
through its binding near the downstream GU-rich element
(48). HnRNP F can interfere with the ability of CstF64 to
bind the RNA by impeding the conformational change
occurring during RNA binding (74) or by multimerizing
and protecting the adjacent GU-rich element. Unlike U1A
or hnRNP F, the inhibitory function of neuron-speciﬁc
members of a family of RNA-binding proteins, Hu
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Figure 2. Schematic drawing of the eukaryotic 30 end processing machineries. Known factors and cis-elements contributing to 30 end processing of
metazoan (A), yeast (B) and plant (C) pre-mRNAs, as described in the text. Homologous factors are color-matched while speciﬁc factors are in gray.
The position of the diﬀerent factors takes into account the RNA-binding speciﬁcity of each factor and, where possible, the protein contacts within
the machinery. The sequence elements that comprise the poly(A) signals are indicated by black rectangles, and the site of cleavage [and subsequent
poly(A) tail addition] is shown by a red dotted-line. In (C) ‘At’ stands for Arabidopsis thaliana.
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tion in the cytoplasm, depends not only on the binding at
sequences adjacent to the AAUAAA hexamer, i.e. the
CPSF binding site, but also on their ability to interact
with both CPSF and CstF (75). This mechanism may
function in conjunction with other factors (see below) to
block polyadenylation of calcitonin (CT)/calcitonin
gene-related peptide (CGRP) exon 4 thus promoting the
neuron-speciﬁc pathway in which exons 5 and 6 are
included in the mature transcript to produce CGRP (76).
30 end processing regulation following the above-
described ‘competition mechanism’ is not restricted to
mammalian factors. The Drosophila master sex-switch
protein Sex-lethal (SXL), involved in both splicing and
translation, competes with CstF64 for binding to the
GU-rich DSE at the proximal poly(A) signal on the
enhancer of rudimentary [e(r)] mRNA. The consequence
of such regulation is to promote a female-speciﬁc
poly(A) switching onto an otherwise distal non-responsive
poly(A) signal. SXL-mediated alternative polyadenylation
may provide a new mechanism for the retention
of an SXL-binding site(s) (in the 30 UTR) in a female
germline-speciﬁc manner for translation repression (77).
Similarly, the yeast hnRNP protein Npl3 inhibits
mRNA 30 end formation by binding G+U-rich sequences
(78), thus preventing the binding of Rna15, the Cstf 64
homolog, to the GAL-7 RNA (79). This regulatory mech-
anism, which depends on the phosphorylation status of
Npl3, might be involved in masking weak or cryptic
poly(A) sites thus ensuring recognition of the proper
poly(A) signal (80).
Inhibitory interaction between PAP and RNA-bound
factors
The RNA-binding activity of a regulatory factor can also
be associated to repression of 30 end processing without
interfering with the association of the core 30 end process-
ing factors to the poly(A) signal. In that case, a protein
bound to deﬁned RNA elements in the vicinity of the AA
UAAA hexamer interacts with PAP to block poly(A) tail
addition (Figure 3B).
One of the best-characterized examples of this regula-
tory mechanism is the autoregulation of U1A pre-mRNA
polyadenylation by the snRNP-free U1A. Cooperative
binding of two U1A molecules to two stem–loop
sequences in the 30 UTR of the U1A pre-mRNA induces
a conformational change that allows a deﬁned region of
the U1A-U1A dimer to interact with the last 20 residues
located at the C-terminus of PAP resulting in inhibition of
polyadenylation (12,81–83). U1A binding to its own
pre-mRNA prevents neither the binding of CPSF, thus
excluding a steric block model, nor the cleavage
reaction, indicating the speciﬁcity of the inhibitory mech-
anism for the polyadenylation step. This mechanism
ensures that the activity of this enzyme, which is essential
to the cell, is only downregulated when U1A, present in
excess in the cell and therefore not engaged in U1 snRNP,
binds the U1A pre-mRNA.
The RNA-dependent inhibition mechanism of PAP
activity is not restricted to autoregulation. Indeed, U1A
bound to three elements upstream of the secretory poly(A)
site of the IgM pre-mRNA selectively inhibits poly-
adenylation in a developmental manner (84). Besides
U1A, other splicing factors have been found to block
poly(A) tail addition when bound upstream of the AAU
AAA. The U170K subunit of the U1 snRNP (85) and the
SR proteins, U2AF65 and SRp75 (86), share both a
protein domain similar to the PAP regulatory domain of
U1A (12) and a similar function in repressing PAP
activity. In these factors the aforementioned domain can
be present in a single or multiple copies and, for U2AF65
and SRp75, it resides in the arginine/serine-rich (RS)
domain (12). In the case of U170K protein, the inhibitory
mechanism involves the binding of the U1 snRNP to
a cryptic 50 splice site located upstream of the BPV
poly(A) signal and is used to repress late gene expression
at early time of viral infection (85).
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Figure 3. Mechanistic models of 30 end processing regulation of
eukaryotic pre-mRNAs. Based on diﬀerent examples of pre-mRNA 30
end processing regulation, eight mechanisms of action can be
delineated. (A) Competition with pA factors for binding to a (C)
Poly(A) signal (pA signal). (B) Inhibitory interaction between PAP
and RNA-bound factors. (C) Poly(A) signal recognition in kinetic com-
petition with splicing and transcription. (D) Recruitment of pA factors
to a poly(A) signal. (E) Redirection to alternative poly(A) sites.
(F) Redistribution of pA factors to the cytoplasm. (G) Redistribution
of pA factors in nuclear complexes. (H) Post-translational modiﬁcation
(PTM) of pre-mRNA 30 end processing factors and regulators. 30 end
processing regulators are in red (negative regulation) or in green
(positive regulation) while pA factors are in white. Protein–protein
interactions are indicated with double-headed harrows while the
RNA-binding activity of regulatory or pA factors is depicted with a
thick, simple arrow in gray.
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of PAP in polyadenylation repression by proteins sharing
the PAP regulatory domain, the question is raised as
to how this interaction inﬂuences the activity of PAP.
Structural determination of this region of PAP alone
and/or in complex with the regulatory proteins will
provide additional information regarding the mechanistic
details of this regulatory mechanism.
Competition with other kinetically linked processes
According to the kinetic model of 30 end processing regu-
lation, the strength of a poly(A) signal is correlated with
the rate of cleavage assembly compared to that of other
temporally and physically linked processes (87), i.e. tran-
scription elongation and splicing (Figure 3C).
This model predicts that protein factors or sequence/
structural elements which modify the rate of processes
competing with cleavage/polyadenylation can aﬀect the
eﬃciency of poly(A) signal recognition. In support of a
kinetic view of poly(A) site utilization, it has been
reported that transcriptional elongation, through eﬀects
on transcriptional pausing or arrest, aﬀect poly(A) site
recognition (2,88–90). Npl3 oﬀers an interesting example
of a protein factor which mediates the competition
between pol II elongation and poly(A) site choice (dis-
cussed above and below). Conversely, factors modifying
the eﬃciency of a poly(A) signal can indirectly inﬂuence
processes which are temporally linked with 30 end process-
ing. In agreement with this, the strength of the poly(A)
signal aﬀects the eﬃciency of transcriptional termination
(91–94). The regulation by ELAV, a neuron-speciﬁc reg-
ulator of pre-mRNA processing of Drosophila, supports a
kinetic link between polyadenylation and splicing. Indeed,
ELAV binds to erect wing (ewg) RNA 30 of a poly(A)
signal within the terminal intron and inhibits 30 end pro-
cessing at this site. The RNA-binding activity of ELAV
together with the presence of a functional poly(A) signal is
required to promote splicing of the terminal intron. Since
ELAV does not interfere with the recognition of the
poly(A) signal by CPSF and CstF, it has been proposed
that the inhibitory activity of ELAV may reside in its
ability to slow down the recruitment of CFI, CFII or
PAP, resulting in delay of the cleavage reaction. The
role of ELAV could be to shift the kinetic competition
between the two processes in favor of the recognition of
the 30 splice site leading to neural-speciﬁc splicing of ewg
pre-mRNA (95).
Recruitment of 30 end processing factors to a 30 end
processing signal
Positive regulation of 30 end processing is mostly achieved
by factors that bind the pre-mRNA and recruit the
polyadenylation machinery through the association with
a cleavage/polyadenylation factor. The interaction
between the regulatory and the basal polyadenylation
factor can be direct or mediated by a bridging factor
(Figure 3D).
The direct recruitment mechanism is used by splicing
factors to mediate the functional interplay between the
splicing and 30 end processing machinery. Three main
actors have been described to be directly involved in this
coupling: U2AF65, U2 snRNP and SRm160. U2AF65,
the large subunit of the U2AF factor, bound to the
pyrimidine tract at the last intron 30 splice site, stimulates
both cleavage and polyadenylation by recruiting the
heterodimeric cleavage factor CFIm 59/25 at the poly(A)
signal (15). This interaction involves the RS region present
in both factors and mediates the ability of the last intron
pyrimidine tract to positively inﬂuence mRNA 30 end for-
mation [(14,16) and references inside]. The U2AF65 RS
region is also involved in the reciprocal regulation, i.e. the
stimulation of splicing by the polyadenylation machinery,
but in this case U2AF65 is tethered on the RNA at the 30
splice site through its interaction with PAP (13). Coupling
between the two processes also requires the functional
interaction between the SF3b subunit of the splicing
factor U2 snRNP bound to the branch point site of the
upstream intron and CPSF associated to the poly(A)
signal (16). The U2 snRNP-dependent function in 30 end
processing is conserved between polyadenylated and
histone pre-mRNAs. Indeed, the SF3b subunit of U2
snRNP, in conjunction with hPrp43, a DEAH-box
helicase, contacts directly a conserved motif within the
histone transcript and stimulates U7 snRNP-dependent
cleavage. This may occur through the interaction
between U2 snRNP and CPSF, which contains CPSF73,
the endonuclease for U7-snRNP-dependent cleavage (96).
Targeting CPSF to stimulate polyadenylation machinery
assembly is the mechanism used also by the SR protein,
SRm160, a splicing coactivator and component of the
splicing-dependent exon junction complex (97). The func-
tional interaction between SRm160 and the 30 end process-
ing machinery is evolutionary conserved and does not
involve the splicing-dependent exon junction complex
(98) but depends on the interaction between the PWI
domain of SRm160 and the pre-mRNA (99).
Besides coupling between splicing and 30 end processing,
the association between CPSF and the AAUAAA
hexamer can be increased by the splicing factor U1A, in
its U1 snRNP-free form (100), probably when bound to
upstream auxiliary sequences playing a positive role in 30
end processing regulation (101). The recruiting mechanism
is also used to modulate poly(A) site selection in speciﬁc
biological processes. The interaction between the WW
domain of the Arabidopsis RNA-binding factor FCA
and the polyadenylation factor FY promotes the choice
of the promoter-proximal polyadenylation site within the
FCA pre-mRNA to produce a transcript encoding a
non-functional protein. This negative autoregulatory
loop contributes to control the Arabidopsis ﬂoral transi-
tion (102).
The indirect mechanism consists in recruiting a pro-
tein factor, which in turn interacts with one component
of the polyadenylation machinery. This mechanism is
exempliﬁed by the splicing factor PTB, that in addition
to playing a repressor role when competing with CstF
binding at DSE (71), is able to stimulate 30 end processing
when associated to upstream elements (35,40,50,103).
The positive function of PTB is mediated by another
splicing and 30 end processing factor, hnRNP H, which
binds to G-rich AuxDSE to stimulate cleavage and
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RNA-binding activity of hnRNP H and, in turn, hnRNP
H recruits either CstF (46,104) or PAP (50) facilitating the
30 end processing reaction. Similarly, the f subunit of the
eukaryotic initiation factor 3 (eIF3f), which co-puriﬁes
with the 30 end processing complex (34), interacts with
both the cyclin-dependent kinase 11 (CDK11) and the
SR splicing regulator 9G8, and modulates cleavage of
the 30 end of the HIV-1 RNA by regulating the
sequence-speciﬁc recognition of 9G8. Since 9G8 interacts
with CFIm (107), this regulatory mechanism is thought to
directly aﬀect the assembly of the 30 end machinery (108).
An indirect recruitment mechanism can also explain how
the 50 cap structure inﬂuences the eﬃciency of 30 end pro-
cessing (109–111). This stimulatory eﬀect is mediated by
the physical association between the nuclear cap binding
complex (CBC) bound at the 50 end and pA factors at the
30 end of the primary transcript; however, this communi-
cation appears to require an unidentiﬁed intermediate(s)
(112). In the case of histone pre-mRNAs, the proposed
model is that CBC is ﬁrst recruited by the negative elon-
gation factor (NELF) and, in turn, CBC associates with
SLBP to determine whether 30 end processing will follow
the stem–loop pathway or the aberrant polyadenylation
pathway (60).
Another interesting example is provided by the recogni-
tion of the human CT/CGRP exon 4 poly(A) signal by
factors bound to a downstream intronic enhancer. This
cis-element increases 30 end processing of the exon 4
poly(A) signal by stimulating the binding of CstF64 to
the RNA (113). A number of factors could mediate this
eﬀect, including the splicing factors U1 snRNP, ASF/SF2,
SRp20 and PTB (113–115). While the mechanism of reg-
ulation by PTB could involve competition between PTB
and U2AF65 for binding to the enhancer pyrimidine tract
(115), SRp20 may function directly by recruiting factors at
the exon 4 poly(A) signal or indirectly by stabilizing the
binding of U1 snRNP which in turn stimulates poly(A)
signal recognition (114).
pA factor-mediated redirection of the 30 end processing
machinery to alternative poly(A) sites
Regulated processing at the pre-mRNA 30 ends can be
induced by the diﬀerential expression of constitutive pA
factors. In most cases, the consequence of this regulatory
mechanism is to promote the selection of alternative
poly(A) signals that ineﬃciently recruit the polyadeny-
lation machinery due to the presence of suboptimal cis-
acting elements (Figure 3E).
According to this model, increased expression of
CstF64 has been associated to alternative polyadenylation
of several pre-mRNAs in various biological situations
(116–120). During B-cell diﬀerentiation, upregulation of
CstF64 is proposed to result in a switch of IgM heavy-
chain mRNA from membrane-bound to a secreted form
(116,117). A similar CstF64 dose-dependent switch from
distal to proximal poly(A) signal selection in the transcript
encoding the transcription factor NF-Atc occurs during
T-cell diﬀerentiation (119). In macrophages, lipopoly-
saccharide stimulation increases CstF levels resulting in
alternative polyadenylation of several pre-mRNAs (118).
More recently, the diﬀerential expression of CFIm
subunits, CFIm25 and CFIm68, in mouse male germ
cells has been correlated to the utilization of alternative
promoter proximal poly(A) signals in a number of tran-
scripts, including those encoding for the regulatory
factors, suggesting autoregulation of both CFIm
subunits (121). In agreement with this study, knocking
down CFIm25 results in alternative poly(A) signal selec-
tion (122). The emerging view is that poly(A) signals
lacking the A(A/U)UAAA hexamer but containing the
CFIm binding site (i.e. the UGUA element) would be
favored under conditions of high CFIm levels, whereas
the distal, often canonical poly(A) signals are used when
the concentration of CFIm is low (121). As in the case of
CstF64, the underlying mechanism is the recruitment of
the polyadenylation machinery to an unfavorable poly(A)
site by the increased binding of a constitutive factor.
pA factor-mediated poly(A) switch can be directed by
mechanisms other than an increase of pA factors’ expres-
sion. The use of the promoter-proximal secretory poly(A)
signal of the immunoglobulin heavy-chain locus is
accompanied by more binding of phosphorylated pol II
CTD and of the transcription elongation factor ELL2 to
the transcription start site region along with more loading
of CstF64 onto pol II. The binding of ELL2 and CstF-64
to pol II is dependent on serine 2 phosphorylation on the
pol II CTD (123). The proposed model is that ELL2
promotes CstF64 binding to phosphorylated pol II and,
as a consequence of this loading, pA factors present at
high local concentration act on the weak secretory-speciﬁc
poly(A) site to direct its recognition and cleavage (124).
Redistribution of pA factors to the cytoplasm
Regulation of the subcellular partitioning of mRNA
binding proteins is an important aspect of the post-trans-
criptional control of gene expression. Recent reports
suggest that this regulatory mechanism inﬂuences not
only the splicing, stability and translation processes
(125) but also the polyadenylation status of the transcripts
(Figure 3F).
The ﬁrst evidence supporting a role for the redistribu-
tion mechanism in controlling 30 end processing was the
regulation of PAP by 14-3-3e, a member of the 14-3-3
protein family (126). This regulation is mediated by a
direct, phosphorylation-dependent interaction between
this factor and the C-terminal region of PAP. The con-
sequence of this interaction is the inhibition of the
polyadenylation activity of PAP and the increase in its
cytoplasmic localization. 30 end processing regulation by
14-3-3e may also lead to a more gene speciﬁc regulation of
mRNA expression by targeting an auxiliary factor of the
polyadenylation machinery. Indeed, activation of 14-3-3e
by the extracellular signal-regulated protein kinase (ERK)
during the heat-shock response induces cytoplasmic
sequestration of the heat-shock transcription factor 1
(HSF1) (127). In addition to inducing transcription of
heat-shock protein (HSP) genes, HSF1 plays a role in
enhancing the polyadenylation eﬃciency of this class of
genes by interacting with symplekin in a stress-induced
2766 Nucleic Acids Research, 2010,Vol.38, No. 9manner (128). Therefore, 14-3-3e-mediated sequestration
of HSF1 in the cytoplasm may contribute to the attenua-
tion of HSF1 nuclear functions in upregulating HSP genes
expression, a process which could take place once the
acute phase of the response to stress is over (127).
More recently, two other factors have been demonstra-
ted to inﬂuence polyadenylation by binding 30 end pro-
cessing factors and inducing their translocation from the
nucleus to the cytoplasm. The cellular stress response 1
gene (CSR1) is a tumor-suppressor protein that interacts
with CPSF73 inducing its redistribution to the cytoplasm
and, as a consequence, inhibition of polyadenylation
(129). It has been proposed that inhibition of CPSF
activity may be the mechanism by which the tumor-
suppressor CSR1 mediates cell death (129). The mecha-
nism of action of the second factor, IP3R-binding protein
released with inositol 1,4,5-triphosphate (IRBIT), a
protein involved in calcium signaling and regulation
of intracellular and extracellular pH, closely resembles
that of 14-3-3e. Indeed, IRBIT binds PAP and the
hFip1 subunit of CPSF in a phosphorylation-dependent
manner and causes both inhibition of polyadenylation and
redistribution of hFip1 into the cytoplasm (130). This reg-
ulatory mechanism takes place in response to oxidative
stress, which leads to modiﬁcation of IRBIT phos-
phorylation status (130).
These examples make clear the importance of the redis-
tribution mechanism in downregulating polyadenylation
in the nucleus. An important unsolved issue is to establish
whether redistribution of nuclear pA factors have conse-
quences on other nuclear (i.e. transcription, capping,
splicing, histone 30 end processing and snRNA processing)
or cytoplasmic (i.e. cytoplasmic polyadenylation) pro-
cesses where 30 end processing factors play also an impor-
tant function.
Redistribution of pA factors in nuclear complexes
The physical association of regulatory factors to the core
processing machinery assembled onto the bipartite
poly(A) signal and subsequent redistribution of these
factors in new protein complexes is a mechanism that
further contributes to modulate 30 end processing eﬃ-
ciency in a positive or in a negative manner (Figure 3G).
Inﬂuenza A infection provides an interesting example of
regulation of 30 end processing by formation of regulatory
complexes with basal pA factors. The eﬀector domain
of inﬂuenza A virus NS1 protein interacts with CPSF30
in inﬂuenza virus-infected cells and inhibits cellular
pre-mRNAs 30 end cleavage and polyadenylation by
preventing the binding of CPSF to the RNA. The
RNA-binding activity of NS1 neither aﬀects the interac-
tion between the two factors, nor inﬂuences the function
of NS1 in polyadenylation regulation or the ability of NS1
to block the accessibility of CPSF (131). The NS1 eﬀector
domain interacts also with PABP forming a NS1–CPSF–
PABP trimeric complex. The physical association of NS1
with PABP leads to polyadenylation inhibition of cellular
pre-mRNAs that escaped cleavage inhibition by NS1. This
may occur by blocking the interaction between PABP and
PAP that is required for processive addition of A residues.
Consequently, via the two-pronged attack against CPSF
and PABP, the NS1 protein blocks 30 end processing of
cellular pre-mRNAs in infected cells. An additional con-
sequence of the interaction with PABP is to inhibit its
nuclear-cytoplasmic shuttling, thus allowing NS1 to
control not only the synthesis of mature transcripts but
also their export to the cytoplasm (132). In other types
of viral infection, the redistribution of factors in RNA
processing complexes could be involved in the poly-
adenylation-mediated switch from early to late gene
expression. Indeed, HSV1 infection causes an increase in
ICP27/IE63 expression and a concomitant reorganization
of splicing components, but not of pA factors, at the site
of transcription. Both events could be responsible of
an enhanced protein binding, including CstF, to weak
poly(A) sites of late genes and as a consequences,
increase processing at these sites (133).
The association between BRCA1-associated protein
BARD1 and CstF50 provides an important link between
30 end processing regulation by this mechanism and DNA
damage. This interaction requires the linker between the
ankyrin and BRCT domains of BARD1 (134). BARD1,
like CstF50 (9), interacts with the pol II CTD while
the protein partner of BARD1, BRCA1, co-immunopre-
cipitates with both CstF64 and BARD1, suggesting the
formation of a BRCA1–BARD1–CstF trimeric complex
connected to the pol II holoenzyme. BARD1, probably
associated with BRCA1, inhibits mRNA 30 end formation
in in vitro functional assays (135). DNA-damage-inducing
agents promote BARD1 phosphorylation (136) and
increase the formation of the BRCA1–BARD1–CstF
trimeric complex. This in turn leads to BARD1-dependent
inhibition of 30 end processing (137). On the basis of the
properties of BARD1, BRCA1 and CstF, it has been
proposed that BARD1, in conjunction with pol II,
senses the sites of DNA damage and the inhibitory
function of the trimeric complex ensures that nascent
RNAs are not erroneously polyadenylated (137).
Positive regulation of 30 end formation by this mecha-
nism is exempliﬁed by the tumor suppressor Cdc73.
This factor associates with the cleavage/polyadenylation
machinery (34) and in particular, with the CPSF-CstF
complex (138). This physical interaction is necessary
for in vitro 30 end processing of model substrates and
is involved in the positive gene-speciﬁc regulation of
polyadenylation in vivo. Cdc73 facilitates the binding of
the two basal factors to actively transcribed chromatin
regions. Since Cdc73 is a component of the pol II and of
the chromatin-associated human Paf1 complex which
orchestrates co-transcriptional histone modiﬁcation, the
functional association of Cdc73 with CstF and CPSF
may help to coordinate transcription and RNA processing
of speciﬁc genes (138).
The HSF1 transcription factor oﬀers another example
that underscores the importance of the functional inter-
play between the transcriptional and 30 end processing
machineries. As described previously, in cells exposed to
stress conditions the transcriptional factor HSF1 forms a
complex with CstF64 and symplekin and this correlates
with increased eﬃciency of Hsp70 mRNA polyadeny-
lation (128). The underlying mechanism could be similar
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recruits CPSF to the promoter for the formation of
mRNA 30 ends (6). Regulated loading of pA factors as
a means to aﬀect 30 end processing may be the mechanism
used by Smicl, a CPSF-interacting protein that trans-
locates from the cytoplasm to the nucleus at the
midblastula transition in Xenopus. Smicl (Smad-
interacting CPSF 30-like) is required for phosphorylation
at serine 2 of pol II and regulates 30 end processing
probably by allowing docking of proteins required for
transcription and cleavage/polyadenylation (139). These
and other molecular interactions may contribute to the
physical tethering between both ends of the gene
observed in yeast and mammalian cells (140).
Redistribution of pA factors by 30 end processing
regulators can also lead to inclusion of additional pA
factors. The nuclear phosphoinositide signaling pathway
involves the nuclear type I phosphatidylinositol
4-phosphate 5-kinases (PIPKIa) and Star-PAP, a novel
enzyme which posses PAP activity. The two enzymes
co-localize at nuclear speckles, interact with each other
and control the expression of genes involved in
detoxiﬁcation and/or oxidative stress response. The under-
lying mechanism of regulation by the oxidative stress
involves an increased association of Star-PAP with
PIPKIa and components of the polyadenylation machin-
ery, and an improved Star-PAP enzymatic activity leading
to a rapid initiation of 30 end formation of this class of
genes (141).
Post-translational modiﬁcation of 30 end processing
factors and regulators
Post-translational modiﬁcation is emerging as an impor-
tant mechanism that contributes to 30 end processing reg-
ulation. It aﬀects the activity of both basal components of
the 30 end processing machinery and regulatory factors.
It contributes to modulate the activity, the nucleus–
cytoplasm partitioning, the stability of the basal factors
and their ability to interact within the core machinery and
with regulatory factors.
Post-translational modiﬁcation of 30 end processing
factors oﬀers an additional layer of 30 end processing reg-
ulation (Figure 3H). Every component of the cleavage/
polyadenylation machinery, though not every subunit, is
aﬀected by this modiﬁcation, including methylation,
sumoylation, acetylation and phosphorylation (142).
The current knowledge on the functional consequences
of these modiﬁcations focuses mainly on PAP.
Phosphorylation of this enzyme occurs throughout the
cell cycle by the cdc2-cyclinB kinase (143,144); however,
in the M-phase, hyperphosphorylation of PAP results in
the downregulation of its activity, which in turn appears
to be important for normal cell growth (143,145). This
regulatory mechanism is inactivated by the HIV-1
Vpr accessory protein which blocks the activity of the
cdc2–cyclinB complex, leading to PAP hyperactivity and
contributing to HIV-1 pathogenesis (146). Phosphory-
lation of PAP can also be a requirement to interact with
a regulatory protein, as shown for 14-3-3e, a protein
factor which inﬂuences both PAP localization and
activity. Hyperphosphorylation of PAP is not relevant
for this interaction, suggesting that the PAP-14-3-3e asso-
ciation may function in phases of the cell cycle other than
the M-phase (126). PAP is also subject to acetylation in its
C-terminal region but this modiﬁcation does not modify
its polyadenylation activity. Instead, acetylated PAP loses
its ability to associate with CFIm25, which is also
acetylated via an interaction between the 68-kDa subunit
of CFIm and the CBP (CREB-binding protein) acety-
transferase. Acetylation of PAP inhibits also the nuclear
localization of PAP by inhibiting the binding to the
importin a/b complex. It has been proposed that this
post-translational modiﬁcation plays a role in the revers-
ible assembly of the 30 end processing complexes (147).
Sumoylation of PAP C-terminus was also found to have
multiple eﬀects on PAP function. In particular,
sumoylation increases the nuclear localization and the
protein stability of PAP but attenuates its enzymatic
activity (148). Sumoylation targets other factors of the 30
end processing machinery, speciﬁcally CPSF73 and
symplekin, thus suggesting that it plays an important
role in 30 end processing complex formation implying a
regulation at diﬀerent levels and multiple protein factors
(149). As demonstrated for sumoylated PAP (148),
post-translational modiﬁcation can regulate the cellular
availability of factors which are required to accomplish
the 30 end processing reaction. During the cell cycle,
replication-dependent histone pre-mRNA 30 end process-
ing plays a critical role in regulating histone mRNAs levels
(150,40) and much of this regulation depends on the levels
of SLBP (151). Degradation of SLBP by the proteasome
at the end of the S-phase is activated by the sequential
action of two kinases, ﬁrst the cyclin A/Cdk1, which is
activated near the end of S-phase, and then the CK2
(152). A diﬀerent mechanism of regulation of the levels
of pA factors is used during the picornavirus infection.
This consists in the proteolytic degradation of CstF64 by
the pircornavirus 3C protease during the viral infection
and leads to inhibition of host 30 end processing. The
consequence of this regulation is to produce less cellular
transcripts and to force the cellular machineries to process
and express the viral RNAs (153).
Recent reports highlight the importance of phosphory-
lation for the regulatory function of auxiliary factors,
regardless of the speciﬁc molecular mechanism used
(Figure 3H). Stress-induced phosphorylation of IRBIT
appears as the major determinant of its interaction with
both hFip1 and PAP. In addition, phosphorylation of
IRBIT controls the ability of this factor to translocate
hFip1 to the nucleus and to inhibit polyadenylation
(130). DNA-damage activated ataxia-telangiectasia
mutated (ATM) kinase phosphorylates BARD1 in the
presence of BRCA1 and this modiﬁcation is relevant for
BARD1 function in mediating repression of polyadeny-
lation and pol II degradation. Importantly, mutation of
BARD1 Tyr734 aﬀects not only DNA-damage functions
but also the ability of BARD1 to interact with CstF, sug-
gesting that formation of the CstF–BARD1 complex
plays an important role in the genotoxic stress-activated
BARD1 functions (136). Another interesting example
is Npl3, a yeast protein that competes with Rna15 for
2768 Nucleic Acids Research, 2010,Vol.38, No. 9binding to a polyadenylation precursor and inhibits
cleavage and polyadenylation in vitro (79). Npl3 plays
also a function in stimulation of the transcriptional elon-
gation activity by interacting with the pol II CTD. Casein
kinase 2 (CK2) was found to be required for the
phosphorylation of Npl3 and to reduce the ability of
Npl3 to compete with Rna15 for binding to poly(A)
signals and to interact with the CTD. This study
suggests that phosphorylation of Npl3 promotes its
dissociation from the mRNA/pol II, and contributes
to the association of the polyA/termination factor
Rna15 (80). Increased levels of Npl3 also result in a
negative-feedback loop in which phosphorylation of
Npl3, probably by a diﬀerent kinase, suppresses eﬃcient
recognition of the productive processing signals in its own
transcript (154).
PERSPECTIVES
Studies over the past 20 years contributed to better char-
acterize the constitutive factors of the basal eukaryotic 30
end processing machineries (depicted in Figure 2) and to
identify many other factors that modulate the eﬃciency
and speciﬁcity of poly(A) signal recognition by these
machineries (Table 1). For some of these factors, the
mechanisms underlying the regulatory function have
been described and overlapping models of regulation can
be proposed (Figure 3 and Supplementary Table S1).
Regulation of 30 end processing eﬃciency and alternative
30 end processing (Figure 1) are increasingly considered as
important steps in gene regulation. Several examples high-
light the essential contribution of 30 end processing in
physiological (e.g. immunity and inﬂammation) or patho-
logical processes (e.g. cancer and viral infection) (25).
Furthermore, evidences for global regulation of alterna-
tive 30 end processing have recently been illustrated.
Strikingly, alternative 30 UTR events show an even
higher frequency of tissue-speciﬁc regulation than other
forms of alternative splicing events (155). A global
change in 30 UTR length, very likely by means of alterna-
tive 30 end processing, occurs during T cell activation
(156), neuronal activation (156), embryonic development
(157), spermatogenesis (121) or oncogene activation (158).
A possible scenario has been proposed in which some
trans-acting factors act globally, some act tissue speciﬁ-
cally, and some act gene speciﬁcally, with the
combinatorial expression of all the diﬀerent trans-acting
factors determining the probability of using each proximal
poly(A) signal (158). Since mechanistic details, that may
help in both the understanding of gene expression regula-
tion and the management of the various diseases in which
30 end processing is associated (25), are often lacking,
future work should be directed toward providing novel
examples to feed the mechanistic models of mRNA
30 end formation proposed here or novel paradigms of
pre-mRNA 30 end processing in eukaryotes.
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